Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$6.19M | -$18.7M | -$33.8M | -$46.3M | -$54.1M | -$74.7M | -$125M | -$172M |
| Net income | -$12.2M | -$16.9M | -$33.3M | -$46.3M | -$53.0M | -$67.7M | -$116M | -$168M |
| EPS (diluted) | -$6.87 | -$4.07 | -$1.44 | -$1.80 | -$1.81 | -$1.65 | -$2.34 | -$2.10 |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.66M | -$16.0M | -$26.8M | -$34.1M | -$46.4M | -$53.5M | -$88.2M | -$131M |
| Capital expenditures | — | $693K | $635K | $1.17M | $2.45M | $687K | $2.21M | $1.23M |
| Free cash flow | — | -$16.7M | -$27.4M | -$35.3M | -$48.8M | -$54.2M | -$90.4M | -$132M |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $33.0M | $136M | $101M | $122M | $81.6M | $193M | $164M | $83.0M |
| Total assets | $34.2M | $141M | $115M | $126M | $117M | $254M | $185M | $165M |
| Total liabilities | — | — | — | $8.38M | $12.4M | $17.5M | $32.7M | $53.0M |
| Shareholders' equity | -$10.7M | $138M | $110M | $118M | $105M | $236M | $152M | $112M |
| Retained earnings | -$12.5M | -$33.0M | -$66.3M | -$113M | -$166M | -$233M | -$349M | -$517M |
| Shares (wtd avg diluted) | 3.85M | 24.0M | 24.1M | 28.9M | 29.4M | 47.8M | 50.7M | 100M |
Every figure is extracted from Cabaletta Bio, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.